Myocardial Injury After Covid-19 mRNA Booster Vaccination

Australian scientists developed an mRNA-based vaccine that effectively stimulates protective immune cell responses against the malaria-causing parasite Plasmodium in preclinical models

Sex-specific differences in myocardial injury incidence after COVID-19 mRNA-1273 Booster Vaccination

Scientists discover DNA contamination in mRNA shots

‘Remarkable’ AI tool designs mRNA vaccines that are more potent and stable

Clinical trial of mRNA universal influenza vaccine candidate begins

Scientists are using mRNA tech to make new flu shots that are more effective

mRNA is taking off – flu vaccines are next

Algorithm for Optimized mRNA Design Improves Stability and Immunogenicity

First-of-its-kind mRNA treatment could wipe out a peanut allergy

It's is now understood that likely the mRNA traveled in the vaccinated mothers milk and was absorbed by the GI tract of the newborn.

Moderna to hire around 2k employees amid mRNA development push

US public investment in critical research contributed to the success of mRNA Covid vaccines, and saved millions of lives

A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium

Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice

mRNA vaccine sequences in blood up to 28 days after Covid-19 vaccination

Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study

Idaho introduces legislation to criminalize those who administer mRNA vaccines

Immunity acquired from a Covid infection was found to be “at least as high, if not higher” than that provided by two doses of an mRNA vaccine

Researchers have developed an analytical platform based on liquid chromatography, mass spectrometry and software analysis that quantifies the structure of messenger RNA (mRNA) medicines

Maternal mRNA covid-19 vaccination during pregnancy was effective against infection or hospital admission in infants for both Delta and Omicron (study on 8809 babies in 🇨🇦)

A study in the US has found, compared to unvaccinated people, protection from the risk of dying from COVID during the six-month omicron wave for folks who had two doses of an mRNA vaccine was 42% for 40- to 59-year-olds; 27% for 60- to 79-year-olds; and 46% for people 80 and older.

Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults - PubMed

mRNA vaccines induce higher long-term IgG4 response versus adenovirus vaccines

Exon architecture controls mRNA m6A suppression and gene expression

The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC

Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis

A bivalent mRNA vaccine targeting omicron BA.4–BA.5 sublineages resulted in neutralization of other SARS-CoV-2 variants similar to that of a fourth dose of a monovalent mRNA vaccine.

A retrospective cohort study shows that previous natural infection was associated with an overall lower incidence of COVID infection than mRNA vaccination

Nanotechnology may improve gene therapy for blindness: Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness

More →